UPDATE: Clovis Oncology Shares Rise 12% Premarket on Positive Phase 1 Trial Results for NSCLC Treatment
March 27, 2014 at 07:54 AM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.